MedTrace Logo

Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)

NCT01278004 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2016-05-26

No results posted yet for this study

Summary

This study is a drug trial of ethosuximide as a painkiller if you develop pain as a side effect of chemotherapy. Ethosuximide will be compared against placebo (an inactive substance) to test whether any response is a true effect of the drug, and not a 'placebo effect'.

Conditions

Interventions

DRUG

Ethosuximide

Drug will be dose escalated in order to reach maximum tolerated dose starting with 250mg.

DRUG

Placebo

Capsule

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01278004 on ClinicalTrials.gov